GlassScriptPhysician profile
Christopher William Hess
NPI 1881848836
$9,220.29
in general payments reported to CMS, 2019-2025
7 companies · $38.63 in 2025
The $38.63 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.95 · 2020: $22.38 · 2023: $4,436 · 2024: $4,634 · 2025: $38.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,800 · Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,800.00 |
| Food and Beverage | $308.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $4,400.00 | 2023 | |
| Saluda Medical Americas, INC. | $4,400.00 | 2024 | Evoke |
| Mentor Worldwide LLC | $246.34 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $88.95 | 2019 | |
| Boston Scientific Corporation | $31.72 | 2024 | Ekosonic |
| Merz North America, INC. | $30.90 | 2024 | |
| Medtronic USA, INC. | $22.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.